Market Place
Sourcing Support
Takeda Receives EU Approval for FRUZAQLA
22 Jun 2024 //
PRESS RELEASE
EpicentRx to Present for PII Trial to Assess Efficacy of RRx-001 vs. regorafenib
20 Jan 2023 //
PR NEWSWIRE
RRx-001 + Irinotecan Significantly Improved PFS Versus Regorafenib in PII Trial
14 Dec 2022 //
PRNEWSWIRE
GCAR Announces That Regorafenib Has Completed Follow-up in the GBM AGILE Trial
21 Sep 2022 //
BUSINESSWIRE
Deciphera Receives EC Approval of QINLOCK for Gastrointestinal Stromal Tumor
22 Nov 2021 //
BUSINESSWIRE
Pimitespib Prolongs Survival in Refractory Gastrointestinal Stromal Tumour
07 Jun 2021 //
FIRSTWORLDPHARMA
Bayer to Present Data from Growing Oncology Portfolio at the ASCO20
11 May 2020 //
BUSINESSWIRE
OnQuality Pharma raises $15m for drug to treat VEGF side effects
30 Oct 2019 //
PHARMAPHORUM
Bristol-Myers Squibb`s Opdivo couldn`t topple Nexavar in HCC
27 Sep 2019 //
ENDPTS
Meet the protein responsible for nearly $100B in cancer drug deals
17 Aug 2019 //
BIOPHARMADIVE
Deciphera success sets up 2-horse race in gastrointestinal cancer
14 Aug 2019 //
BIOPHARMADIVE
Deciphera soars as phase 3 cancer data tee up FDA filing
13 Aug 2019 //
FIERCE BIOTECH
Bayer, BMS, Ono to Collaborate on Colorectal Cancer Treatments
19 Jul 2019 //
CONTRACT PHARMA
Bayer’s move to block Natco’s colorectal cancer brand dismissed by Delhi HC
16 Jul 2019 //
ECONOMIC TIMES
Bristol-Myers Squibb’s Opdivo misses its shot at earlier use in liver cancer
25 Jun 2019 //
FIERCE PHARMA
Bayer hunts for rare glioblastoma nod with `Big 5` contender
21 Jun 2019 //
FIERCE PHARMA
CStone and Bayer announce collaboration to evaluate PD-L1 monoclonal antibody
11 Jun 2019 //
PR NEWSWIRE
Stivarga final NICE recommendation for hepatocellular carcinoma
09 Jan 2019 //
PHARMA TIMES
Can A Cancer Drug Originated In China Be A Success In The U.S.?
13 Sep 2018 //
FORBES
Adempas maker Bayer launches new hypertension support group
14 Jul 2018 //
FIERCE PHARMA
Blueprint Medicines Initiates VOYAGER Ph3 Clinical Trial of Avapritinib
21 May 2018 //
PRESS RELEASE
Five therapies endorsed for use on NHS Scotland
08 May 2018 //
PARMA TIMES
Bayer`s growth-driving quintet? Better, thanks to Stivarga & Xofigo stall
03 May 2018 //
FIERCE PHARMA
Liver cancer patients barred from NHS access to Bayer’s Stivarga
09 Feb 2018 //
PHARMA TIMES
Bayer’s Stivarga wins NICE approval for GIST
20 Nov 2017 //
PHARMA TIMES
NICE shoots down Bayer`s Stivarga in liver cancer
08 Nov 2017 //
FIERCE PHARMA
NICE gives final draft guidance on two key cancer drugs
12 Oct 2017 //
PHARMAFILE
NICE approves Bayer`s Nexavar for primary liver cancer
11 Aug 2017 //
PHARMA TIMES
EMA clears Bayer`s Stivarga for liver cancer
08 Aug 2017 //
PMLIVE
Bayer Receives FDA Approval for Stivarga for the II-Line S-Treatment
27 Apr 2017 //
MULTIVI
FDA Approves Bayer`s Stivarga for Liver Cancer
27 Apr 2017 //
PHARMAMANUFACTURING
Another record year for Bayer – good progress with the acquisition of Monsanto
23 Feb 2017 //
PRESS RELEASE
Bayer`s hefty 2016 growth underlines danger of neglecting R&D for Monsanto
22 Feb 2017 //
FIERCE PHARMA
Eisai`s Lenvima moves toward Nexavar showdown with phase 3 liver cancer win
26 Jan 2017 //
FIERCE PHARMA
Bayer`s struggling Stivarga moves closer to liver-cancer lifeline
04 Jan 2017 //
FIERCE PHARMA
FDA Grants Bayer Priority Review for Stivarga
04 Jan 2017 //
PR NEWSWIRE
Bayer seeks expanded marketing nod from US, Japan & EU
08 Nov 2016 //
PHARMABIZ
Bayer applies for Regorafenib authorization to treat liver cancer
07 Nov 2016 //
REUTERS
Bayer counts on Nexavar-Stivarga `continuum` to protect its liver-cancer lead
11 Oct 2016 //
FIERCE PHARMA
Biotech targets Bayer growth hope Stivarga with IPR challenge
06 Aug 2016 //
FIERCE PHARMA
Bayer growth hope Stivarga boosts survival in liver cancer patients
29 Jun 2016 //
FIERCE PHARMA
PIII Data Show Bayer`s Stivarga Improved Overall Survival in Liver Cancer
28 Jun 2016 //
PR NEWSWIRE
Bayer Collaborates with U.S. National Surgical Adjuvant Breast and Bowel Project (NSABP)
31 May 2016 //
PR NEWSWIRE
Bayer plots Stivarga expansion with new top-line data in hand
05 May 2016 //
FIERCE PHARMA
Bayer says its drug extends lives of liver cancer patients
05 May 2016 //
REUTERS
Sanofi’s weak Q1 cancer drug sales spur Medivation buyout desire
29 Apr 2016 //
FIERCE PHARMA
Incyte stops tests on Jakafi to treat colorectal cancer
27 Jan 2016 //
REUTERS
Bayer to Highlight Latest Stivarga(regorafenib) Tablet Research at ASCO GI 2016
19 Jan 2016 //
PR NEWS WIRE
Two new drugs are registered by Anvisa
28 Dec 2015 //
ANVISA
U.S. cancer doctors drop pricey drugs with little or no effect
09 Oct 2015 //
REUTERS
Disappointment for pharma with new Cancer Drugs Fund list
27 May 2015 //
PM LIVE
Bayer`s Stivarga wins appeal to stay on CDF
23 May 2015 //
PHARMA TIMES
Eylea Growth Closes the Gap With Lucentis
02 May 2015 //
PM LIVE
Strong start to the year for Bayer
01 May 2015 //
WORLD PHARMA NEWS
Seven New Drugs OK`d For NHS Scotland
14 Apr 2015 //
PHARMA TIMES
Government Slams Big Drug Companies For Pushing Costly Cancer Drugs With Limited Benefits
19 Mar 2015 //
ABC NEWS
Bayer Says Won`t Get Results from Stivarga Trial in Bowel Cancer
05 Mar 2015 //
REUTERS
Bayer`s Eylea Cleared for Wider Use in Europe
27 Feb 2015 //
PMLIVE
Bayer Nabs New Eylea Nod to Help it Toward 2015 Sales Target
27 Feb 2015 //
FIERCE PHARMA
Bayer Counts On Consumer Health, Pharma Growth to Power 2015
26 Feb 2015 //
FIERCE PHARMA
